{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T07:06:06Z","timestamp":1769756766692,"version":"3.49.0"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2013,8,12]],"date-time":"2013-08-12T00:00:00Z","timestamp":1376265600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0073250","type":"journal-article","created":{"date-parts":[[2013,8,12]],"date-time":"2013-08-12T21:14:42Z","timestamp":1376342082000},"page":"e73250","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":39,"title":["Predictors of Death during Tuberculosis Treatment in TB\/HIV Co-Infected Patients in Malaysia"],"prefix":"10.1371","volume":"8","author":[{"given":"Ismawati","family":"Ismail","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Awang","family":"Bulgiba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,8,12]]},"reference":[{"key":"ref1","article-title":"TB\/HIV- A clinical manual","year":"2004"},{"key":"ref2","article-title":"Global","year":"2012"},{"key":"ref3","article-title":"Global tuberculosis control","year":"2011"},{"key":"ref4","first-page":"2011","article-title":"atl Strateg Plan TB Control Malays","year":"2011"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/QAI.0b013e318177594e","article-title":"Antiretroviral therapy for HIV-infected tuberculosis patients saves lives but needs to be used more frequently in Thailand","volume":"48","author":"NMD Sanguanwongse","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref6","first-page":"325","article-title":"Impact of drug-resistant tuberculosis on the survival of HIV-infected patients","volume":"11","author":"S Sungkanuparph","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/01.qai.0000230521.86964.86","article-title":"Survival rate and risk factors of mortality among HIV\/tuberculosis- coinfected patients with and without antiretroviral therapy","volume":"43","author":"W Manosuthi","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref8","first-page":"2001","article-title":"HIV-associated TB in An Giang Province","author":"TT Thuy","year":"2007","journal-title":"Vietnam"},{"key":"ref9","first-page":"1998","article-title":"Characteristics of HIV-infected tuberculosis patients in Kota Bharu","author":"Z Mohammad","year":"2004","journal-title":"Hospitals"},{"key":"ref10","first-page":"946","article-title":"Tuberculosis in HIV\/AIDS patients: a Malaysian experience","volume":"36","author":"V Nissapatorn","year":"2005","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"ref11","article-title":"Practice guidelines for the control and management of tuberculosis: 51","year":"2002"},{"key":"ref12","article-title":"Treatment of tuberculosis guidelines","year":"2010"},{"key":"ref13","article-title":"TB Control Program in Malaysia, Annual","year":"2012"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/0035-9203(95)90668-1","article-title":"The impact of human immunodeficiency virus on mortality of patients treated for tuberculosis in a cohort study in Zambia","volume":"89","author":"AM Elliott","year":"1995","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0035-9203(98)91036-7","article-title":"Treatment outcome of an unselected cohort of tuberculosis patients in relation to human immunodeficiency virus serostatus in Zomba Hospital, Malawi","volume":"92","author":"Harries","year":"1998","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.4269\/ajtmh.2006.75.1027","article-title":"Tuberculosis mortality, drug resistance, and infectiousness in patients with and without HIV infection in Peru","volume":"75","author":"V Kawai","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"ref17","first-page":"409","article-title":"Factors associated with mortality in HIV-infected and uninfected patients with pulmonary tuberculosis","volume":"9","author":"FM Mugusi","year":"2009"},{"key":"ref18","first-page":"45","article-title":"Treatment outcomes by drug resistance and HIV status among tuberculosis patients in Ho Chi Minh City, Vietnam","volume":"10","author":"HT Quy","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref19","first-page":"547","article-title":"Impact of human immunodeficiency virus infection on the outcome of treatment and survival of tuberculosis patients in Mwanza, Tanzania","volume":"2","author":"J Van den Broek","year":"1998","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref20","article-title":"Bird a R, Nell H","author":"CD Morris","year":"1989"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/nature09247","article-title":"An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis","volume":"466","author":"MPR Berry","year":"2010","journal-title":"Nature"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1365-2249.2006.03144.x","article-title":"Changes in leukocyte and lymphocyte subsets during tuberculosis treatment; prominence of CD3<sup>dim<\/sup>CD56<sup>+<\/sup> natural killer T cells in fast treatment responders","volume":"145","author":"H Veenstra","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"ref23","first-page":"e1002464","article-title":"Tuberculosis and HIV Co-Infection","volume":"8","author":"A Pawlowski","year":"2012"},{"key":"ref24","first-page":"263","article-title":"Survival of a large cohort of HIV-infected tuberculosis patients in the era of highly active antiretroviral treatment","volume":"15","author":"L Catal\u00e0","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1097\/QAD.0b013e3283326879","article-title":"Mortality from HIV and TB co-infections is higher in Eastern Europe than in Western Europe and Argentina","volume":"23","author":"DN Podlekareva","year":"2009","journal-title":"AIDS"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s150100050038","article-title":"Negative predictors of survival in HIV-infected patients with culture-confirmed pulmonary tuberculosis","volume":"27","author":"F Palmieri","year":"1999","journal-title":"Infection"},{"key":"ref27","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/931325","article-title":"Impact of previous ART and of ART initiation on outcome of HIV-associated tuberculosis","volume":"2012","author":"E Girardi","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/00002030-199704000-00008","article-title":"Site of disease and opportunistic infection predict survival in HIV-associated tuberculosis","volume":"11","author":"C Whalen","year":"1997","journal-title":"AIDS"},{"key":"ref29","first-page":"e47542","article-title":"Causes of death on antiretroviral therapy: a post-mortem study from South Africa","volume":"7","author":"EB Wong","year":"2012"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/00126334-200104010-00006","article-title":"Changing clinical presentation and survival in HIV-associated tuberculosis after highly active antiretroviral therapy","volume":"26","author":"E Girardi","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1089\/apc.2009.0030","article-title":"HIV-specific health care utilization and mortality among tuberculosis\/HIV coinfected persons","volume":"23","author":"LB Gadkowski","year":"2009","journal-title":"AIDS Patient Care STDs"},{"key":"ref32","first-page":"42","article-title":"HIV care and treatment factors associated with improved survival during TB treatment in Thailand: an observational study","volume":"9","author":"JK Varma","year":"2009"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/QAI.0b013e31819367e7","article-title":"Effect of simultaneous use of highly active antiretroviral therapy on survival of HIV patients with tuberculosis","volume":"50","author":"MMDP Velasco","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1056\/NEJMoa0905848","article-title":"Timing of initiation of antiretroviral drugs during tuberculosis therapy","volume":"362","author":"SS Abdool Karim","year":"2010","journal-title":"N Engl J Med"},{"key":"ref35","first-page":"1471","article-title":"Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis","volume":"16","author":"FX Blanc","year":"2011"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1056\/NEJMoa1013607","article-title":"Timing of antiretroviral therapy for HIV-1 infection and tuberculosis","volume":"365","author":"DV Havlir","year":"2011","journal-title":"N Engl J Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1093\/infdis\/jir503","article-title":"A randomized trial of punctuated antiretroviral therapy in Ugandan HIV-seropositive adults with pulmonary tuberculosis and CD4<sup>+<\/sup> T-cell counts of \u2265 350 cells\/\u00b5L","volume":"204","author":"MW Nanteza","year":"2011","journal-title":"J Infect Dis"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1056\/NEJMoa1014181","article-title":"Integration of antiretroviral therapy with tuberculosis treatment","volume":"365","author":"SS Abdool Karim","year":"2011","journal-title":"N Engl J Med"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/clind\/24.4.661","article-title":"A prospective study of tuberculosis and human immunodeficiency virus infection: clinical manifestations and factors associated with survival","volume":"24","author":"PL Alpert","year":"1997","journal-title":"Clin Infect Dis"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00002030-199603000-00005","article-title":"Predictors of survival in HIV-infected tuberculosis patients","volume":"10","author":"RW Shafer","year":"1996","journal-title":"AIDS"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/jac\/37.suppl_B.113","article-title":"Mycobacteriosis and HIV infection: the new public health challenge","volume":"37","author":"JDH Porter","year":"1996","journal-title":"J Antimicrob Chemother"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0073250","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T16:46:43Z","timestamp":1646326003000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0073250"}},"subtitle":[],"editor":[{"given":"Robert\u00a0J","family":"Wilkinson","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,8,12]]},"references-count":41,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2013,8,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0073250","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,12]]}}}